Interleukin-6 receptor: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 24: | Line 24: | ||
{{protein-stub}} | {{protein-stub}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 15:15, 17 March 2025
Interleukin-6 receptor (IL-6R) is a type of protein that in humans is encoded by the IL6R gene. It is a component of the immune system and plays a crucial role in inflammation and immune response.
Structure[edit]
The IL-6R protein is a type I cytokine receptor, which is characterized by the presence of a transmembrane domain. It is composed of two subunits: an alpha chain (IL-6Rα) and a beta chain (gp130). The alpha chain is responsible for ligand binding, while the beta chain is involved in signal transduction.
Function[edit]
The primary function of the IL-6R is to mediate the effects of interleukin-6 (IL-6), a cytokine that plays a central role in immune response, inflammation, and hematopoiesis. When IL-6 binds to the IL-6R, it triggers a cascade of intracellular signaling events that ultimately lead to the activation of various immune cells.
Clinical significance[edit]
Alterations in the IL-6/IL-6R signaling pathway have been implicated in a variety of diseases, including rheumatoid arthritis, systemic lupus erythematosus, and cancer. In addition, therapeutic strategies targeting the IL-6/IL-6R pathway are currently being explored for the treatment of these and other diseases.
See also[edit]
References[edit]
<references />

